683 Capital Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

683 Capital Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-233,333	Closed	-$3.36M	–	249
2021 Q2	$3.36M	Buy	+233,333	New	+$1.17M	0.12%	98

683 Capital Management's CEREW Position: Q3 2021 in Review

683 Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 233,333 shares — an estimated $3.36M sold.

683 Capital Management first reported a position in CEREW in Q2 2021 and held it in 1 quarter. The position peaked at $3.36M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

683 Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
683 Capital Management sold 233,333 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $3.36M.
683 Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q2 2021 and held it in 1 quarter.
683 Capital Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $3.36M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on 683 Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.